Target intelligence / Profile preview

Lethal-7d-3p microRNA (let-7d-3p)

Target
let-7d-3p
Molecular classification
MicroRNA, Non-coding RNA, let-7 family
01

Overview

Lethal-7d-3p microRNA (let-7d-3p) is a small, non-coding RNA molecule belonging to the highly conserved let-7 family, which is essential for regulating gene expression at the post-transcriptional level [1, 5]. It functions primarily by binding to the 3' untranslated regions (3' UTR) of target messenger RNAs, leading to their degradation or the inhibition of their translation into proteins [2, 12]. In many contexts, let-7d-3p acts as a tumor suppressor by targeting oncogenes such as KRAS, HMGA2, and C-MYC, and its downregulation is frequently observed in various cancers, including ovarian and cervical malignancies [1, 13]. Beyond oncology, let-7d-3p is involved in the pathophysiology of cardiovascular diseases like heart failure and inflammatory conditions such as sepsis, where it often serves as a circulating biomarker for diagnosis and prognosis [6, 7]. Therapeutic strategies targeting let-7d-3p include the use of miRNA mimics to restore its function in disease states or antisense oligonucleotides (antimiRs) to inhibit its activity when it is pathologically upregulated [2, 10]. However, the clinical application of these therapies faces challenges related to precise delivery and the potential for off-target effects due to the miRNA's ability to regulate multiple gene targets simultaneously [14, 15]. Its role in neurogenesis and mood disorders also suggests potential applications in psychiatric therapy [9].

Other names
hsa-let-7d-3plet-7d-3plet-7d*MIMAT0004484MicroRNA let-7d-3p
02

Mechanism of action

Binds to the 3' untranslated region (3' UTR) of target mRNAs to induce translational repression or mRNA cleavage

03

Biological functions

Post-transcriptional gene regulationCell proliferationApoptosisAngiogenesisImmune responseCell differentiationNeurogenesis
04

Disease associations

CancerInfectionCardiovascular diseaseInflammationOther
05

Safety considerations

Off-target effectsSystemic delivery challengesPotential for innate immune response activation
06

Interacting drugs

let-7d mimic

1 more in the full profile.

07

Biomarkers

Sepsis diagnostic biomarkerCervical cancer diagnostic biomarkerHeart failure prognostic biomarkerAcute lung injury biomarker

Beyond the preview

Go deeper on Lethal-7d-3p microRNA (let-7d-3p).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lethal-7d-3p microRNA (let-7d-3p).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call